ContentsIN MY OPINIONCONQUERING CHALLENGES AND BROADENING OPPORTUNITIES: THE JOURNEY TO BRINGING INNOVATIVE CELL THERAPIES TO PATIENTSTamara J. Laskowski, Global Head, Clinical & Process Development, Lonza Personalized Medicine, LonzaLAST WORD08BIOTECHNOLOGY SHOULD HAVE PREFERRED REGULATORY PATHWAYS TO CATALYZE THE BIOSCIENCE REVOLUTIONLone Dybdal Nilsson, VP of Applied Research in Agriculture and Industrial Bioprocessing, Novozymes30COVER STORY12FUTURE-PROOFING CLINICAL APPLICATIONS WITH SECURE CLOUD ENVIRONMENTKeith Parent, CEOTOP 10SOLUTIONS PROVIDERS 2024SCIENCES TECHPHARMA AND LIFE
< Page 3 | Page 5 >